Hepatitis C and hepatocellular carcinoma
作者： Benjamin H. Leach , Jonathan M. Schwartz
DOI: 10.1007/S11901-007-0009-4
关键词: Hepatology 、 Hepatocellular carcinoma 、 Medicine 、 Cirrhosis 、 Hepatitis 、 Hepatitis C 、 Chronic hepatitis 、 Internal medicine 、 In patient 、 Gastroenterology
摘要: The risk of hepatocellular carcinoma (HCC) is greatly increased in patients with cirrhosis resulting from chronic hepatitis C infection. Diagnosis and treatment HCC remain difficult mortality high. Surveillance individuals who are at recommended, the can likely be reduced by treating underlying hepatitis.
springer.com
elsevier.com
sci-hub.se 参考文章(34)
Oscar Arrieta, Bernardo Cacho, Daniela Morales-Espinosa, Ana Ruelas-Villavicencio, Diana Flores-Estrada, Norma Hernández-Pedro, The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis BMC Cancer. ,vol. 7, pp. 28- 28 ,(2007) , 10.1186/1471-2407-7-28
Yasuji Arase, Kenji Ikeda, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Masahiro Kobayashi, Norio Akuta, Takashi Someya, Rikako Koyama, Tetsuya Hosaka, Hitomi Sezaki, Mariko Kobayashi, Hiromitsu Kumada, Long-term outcome after interferon therapy in elderly patients with chronic hepatitis C. Intervirology. ,vol. 50, pp. 16- 23 ,(2007) , 10.1159/000096308
Savino Bruno, Tommaso Stroffolini, Massimo Colombo, Simona Bollani, Luisa Benvegnù, Giuseppe Mazzella, Antonio Ascione, Teresa Santantonio, Felice Piccinino, Pietro Andreone, Alessandra Mangia, Giovanni B. Gaeta, Marcello Persico, Stefano Fagiuoli, Piero L. Almasio, , Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study Hepatology. ,vol. 45, pp. 579- 587 ,(2007) , 10.1002/HEP.21492
Valérie Paradis, Pierre Bedossa, In the new area of noninvasive markers of hepatocellular carcinoma. Journal of Hepatology. ,vol. 46, pp. 9- 11 ,(2007) , 10.1016/J.JHEP.2006.10.006
Jean-Baptiste Nousbaum, Stanislas Pol, Bertrand Nalpas, Paul Landais, Pierre Berthelot, Christian Brechot, Collaborative Study Group*, None, Hepatitis C Virus Type 1b (II) Infection in France and Italy Annals of Internal Medicine. ,vol. 122, pp. 161- 168 ,(1995) , 10.7326/0003-4819-122-3-199502010-00001
D G Ward, Y Cheng, G N'kontchou, T T Thar, N Barget, W Wei, L J Billingham, A Martin, M Beaugrand, P J Johnson, Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. British Journal of Cancer. ,vol. 94, pp. 287- 292 ,(2006) , 10.1038/SJ.BJC.6602923
Kazuki Ikeda, Hiroyuki Marusawa, Yukio Osaki, Takefumi Nakamura, Naoto Kitajima, Yukitaka Yamashita, Masatoshi Kudo, Tosiya Sato, Tsutomu Chiba, Antibody to Hepatitis B Core Antigen and Risk for Hepatitis C–Related Hepatocellular Carcinoma: A Prospective Study Annals of Internal Medicine. ,vol. 146, pp. 649- 656 ,(2007) , 10.7326/0003-4819-146-9-200705010-00008
L B Seeff, J H Hoofnagle, Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene. ,vol. 25, pp. 3771- 3777 ,(2006) , 10.1038/SJ.ONC.1209560
Bo-Heng Zhang, Bing-Hui Yang, Zhao-You Tang, Randomized controlled trial of screening for hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. ,vol. 130, pp. 417- 422 ,(2004) , 10.1007/S00432-004-0552-0
Mindie H. Nguyen, Ruel T. Garcia, Peter W. Simpson, Teresa L. Wright, Emmet B. Keeffe, Racial differences in effectiveness of α‐fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis Hepatology. ,vol. 36, pp. 410- 417 ,(2002) , 10.1053/JHEP.2002.34744